Class II
Drug Recall: UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323
MXBBB · November 14, 2024
Reason for Recall
cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.
Distribution
Product was sold via Amazon Marketplace.
Quantity Affected
321 bottles
Source: FDA (openFDA Drug Enforcement)
Recall number: D-0166-2025
Status: ongoing
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.